Thomas Kurt Eigentler1, Joachim Hinderer2, Seema Noor3, Claus Garbe3, Ulrike Leiter3. 1. Department of Dermatology, University-Hospital-Tübingen, Eberhard-Karls-University, Liebermeisterstrasse 25, 72076, Tübingen, Germany. thomas.eigentler@med.uni-tuebingen.de. 2. Klinikum Sindelfingen-Böblingen, Kliniken Sindelfingen, Arthur-Gruber-Straße 70, 71065, Sindelfingen, Germany. 3. Department of Dermatology, University-Hospital-Tübingen, Eberhard-Karls-University, Liebermeisterstrasse 25, 72076, Tübingen, Germany.
Abstract
BACKGROUND: Sentinel node (SN) biopsy is regarded as standard of care for patients (pts) with cutaneous melanoma ≥1.0 mm of thickness. In the recent AJCC classification, findings in the SN are simply classified as positive or negative. In our analyses, we were interested whether quantitative real-time PCR (qRT-PCR) is able to predict disease-free survival (DFS) and overall survival (OS) depending on tumour burden in the SN. METHODS: One hundred and forty-five pts were analysed using qRT-PCR for tyrosinase. Results were analysed using accelerated failure time survival model and cox proportional hazards models using the R statistics framework. RESULTS: Forty-one pts (28%) were positive according to qRT-PCR. In total, 12 of 41 pts showed tumour deposits in the SN using S100 and/or HMB-45-labelled immunohistochemistry as well. One patient had micrometastases detected by immunohistochemistry staining but failed in the qRT-PCR. After 10 years of follow-up, 34 patients recurred and 27 patients died. Significant differences for DFS and OS were detected for sex, increasing tumour thickness, ulceration of the primary tumour, and metastatic spread in the SN determined by histology as well as qRT-PCR. CONCLUSION: Quantitative analyses showed a logarithmic correlation between tumour burden and prognosis. However, as multivariate analyses reveal qRT-PCR was not superior compared to classical histology or immunohistology.
BACKGROUND: Sentinel node (SN) biopsy is regarded as standard of care for patients (pts) with cutaneous melanoma ≥1.0 mm of thickness. In the recent AJCC classification, findings in the SN are simply classified as positive or negative. In our analyses, we were interested whether quantitative real-time PCR (qRT-PCR) is able to predict disease-free survival (DFS) and overall survival (OS) depending on tumour burden in the SN. METHODS: One hundred and forty-five pts were analysed using qRT-PCR for tyrosinase. Results were analysed using accelerated failure time survival model and cox proportional hazards models using the R statistics framework. RESULTS: Forty-one pts (28%) were positive according to qRT-PCR. In total, 12 of 41 pts showed tumour deposits in the SN using S100 and/or HMB-45-labelled immunohistochemistry as well. One patient had micrometastases detected by immunohistochemistry staining but failed in the qRT-PCR. After 10 years of follow-up, 34 patients recurred and 27 patients died. Significant differences for DFS and OS were detected for sex, increasing tumour thickness, ulceration of the primary tumour, and metastatic spread in the SN determined by histology as well as qRT-PCR. CONCLUSION: Quantitative analyses showed a logarithmic correlation between tumour burden and prognosis. However, as multivariate analyses reveal qRT-PCR was not superior compared to classical histology or immunohistology.
Authors: H J Blaheta; U Ellwanger; B Schittek; K Sotlar; E MacZey; H Breuninger; M H Thelen; B Bueltmann; G Rassner; C Garbe Journal: J Invest Dermatol Date: 2000-04 Impact factor: 8.551
Authors: A C J van Akkooi; J H W de Wilt; C Verhoef; P I M Schmitz; A N van Geel; A M M Eggermont; M Kliffen Journal: Ann Oncol Date: 2006-09-12 Impact factor: 32.976
Authors: Alexander M M Eggermont; Stefan Suciu; Mario Santinami; Alessandro Testori; Wim H J Kruit; Jeremy Marsden; Cornelis J A Punt; François Salès; Martin Gore; Rona Mackie; Zvonko Kusic; Reinhard Dummer; Axel Hauschild; Elena Musat; Alain Spatz; Ulrich Keilholz Journal: Lancet Date: 2008-07-12 Impact factor: 79.321
Authors: Anja Ulmer; Klaus Dietz; Isabelle Hodak; Bernhard Polzer; Sebastian Scheitler; Murat Yildiz; Zbigniew Czyz; Petra Lehnert; Tanja Fehm; Christian Hafner; Stefan Schanz; Martin Röcken; Claus Garbe; Helmut Breuninger; Gerhard Fierlbeck; Christoph A Klein Journal: PLoS Med Date: 2014-02-18 Impact factor: 11.069